Профили пользователей по запросу "J. Rettig"

Jens Rettig

Saarland University
Подтвержден адрес электронной почты в домене uks.eu
Цитируется: 9913

…, RA Price, HG Hills, YL Qiu, KA Kron, JH Rettig… - Annals of the Missouri …, 1993 - JSTOR
We present the results of two exploratory parsimony analyses of DNA sequences from 475
and 499 species of seed plants, respectively, representing all major taxonomic groups. The
data are exclusively from the chloroplast gene rbcL, which codes for the large subunit of …

J Rettig, SH Heinemann, F Wunder, C Lorra, DN Parcej… - Nature, 1994 - nature.com
Structural and functional diversity of voltage-gated K v 1-type potassium channels in rat
brain is enhanced by the association of two different types of subunits, the membrane-
bound, pore-forming α-subunits and a peripheral β-subunit. We have cloned a β-subunit (K v …

[HTML][HTML]

…, GI Shapiro, A Baum, F Himmelsbach, WJ Rettig… - Oncogene, 2008 - nature.com
Genetic alterations in the kinase domain of the epidermal growth factor receptor (EGFR) in
non-small cell lung cancer (NSCLC) patients are associated with sensitivity to treatment with
small molecule tyrosine kinase inhibitors. Although first-generation reversible, ATP …

…, G Bader, A Zoephel, J Quant, A Heckel, WJ Rettig - Cancer research, 2008 - AACR
Inhibition of tumor angiogenesis through blockade of the vascular endothelial growth factor
(VEGF) signaling pathway is a novel treatment modality in oncology. Preclinical findings
suggest that long-term clinical outcomes may improve with blockade of additional …

[HTML][HTML]

…, M Grauert, GR Adolf, N Kraut, JM Peters, WJ Rettig - Current biology, 2007 - Elsevier
Fine-mapping of the cell-division cycle, notably the identification of mitotic kinase signaling
pathways, provides novel opportunities for cancer-drug discovery. As a key regulator of
multiple steps during mitotic progression across eukaryotic species, the serine/threonine …

…, LJ Old, WJ Rettig - Proceedings of the …, 1990 - National Acad Sciences
The F19 antigen is a cell surface glycoprotein (Mr, 95,000) of human sarcomas and
proliferating, cultured fibroblasts that is absent from resting fibroblasts in normal adult
tissues. Normal and malignant epithelial cells are also F19-. The present …

[HTML][HTML]

…, B Di Fiore, JJ Lipp, M Hoffmann, WJ Rettig… - Current biology, 2007 - Elsevier
Summary Background The mitotic kinases, Cdk1, Aurora A/B, and Polo-like kinase 1 (Plk1)
have been characterized extensively to further understanding of mitotic mechanisms and as
potential targets for cancer therapy. Cdk1 and Aurora kinase studies have been facilitated by …

…, JH Healey, LJ Old, WJ Rettig - Proceedings of the …, 1994 - National Acad Sciences
The human fibroblast activation protein alpha (FAP alpha) is a M (r) 95,000 cell surface
antigen selectively expressed in reactive stromal fibroblasts of epithelial cancers,
granulation tissue of healing wounds, and malignant cells of bone and soft tissue sarcomas …

…, PE Saigo, JL Lewis Jr, LJ Old, WJ Rettig - The American journal …, 1993 - ncbi.nlm.nih.gov
The LK26 antigen is a cell surface glycoprotein (M (r) 35,000 to 40,000) of normal placenta
and gestational choriocarcinomas that shows highly restricted distribution in normal tissues,
being expressed primarily in a subset of simple epithelia. In this study, immunohistochemical …

SJ Ahn, J Costa, J Rettig Emanuel - Nucleic acids research, 1996 - academic.oup.com
PCR has become a powerful tool for genetic analysis and many applications for gene
sequence quantitation are based on this technology (1–3). Standardized reaction conditions
require accurate quantitation of input DNA as well as optimization of chemical and cycling …